SBIR-STTR Award

Purification of Vitamin D Receptor for Crystallization
Award last edited on: 3/3/02

Sponsored Program
SBIR
Awarding Agency
NIH : NIDDK
Total Award Amount
$71,588
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Elizabeth Allegretto

Company Information

Ligand Pharmaceuticals Inc (AKA: Progenx Inc)

3911 Sorrento Valley Boulevard Suite 110
San Diego, CA 92121
   (858) 550-7500
   investors@ligand.com
   www.ligand.com
Location: Single
Congr. District: 52
County: San Diego

Phase I

Contract Number: 1R43DK048197-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1994
Phase I Amount
$71,588
Awardee's statement of the potential commercial applications of the research:The crystal structure of the vitamin D receptor will allow for a rational approach to drug design for vitamin D agonists and/or antagonists. Our screening assay compliments this approach by providing a quick, efficient, random screen for vitamin D mimetics. Together these two techniques will help Identify compounds that have indications in osteoporosis, leukemia, cancer, and psoriasis.National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----